Abstract Non-celiac gluten sensitivity (NCGS) is a condition in which symptoms are triggered by gluten ingestion, in which both allergic and autoimmune mechanisms have been ruled out. The ''classical'' presentation of NCGS is a combination of gastrointestinal symptoms (including abdominal pain, bloating, and bowel habit abnormalities) and extra-intestinal manifestations. So far, NCGS has been described extensively in adults, and few data are available for the pediatric population. Due to lack of a serological or histological marker, the diagnosis of NCGS remains clinical and it is based on the exclusion of celiac disease and wheat allergy and on gluten challenge. G is a 2.5-year-old child referred to our Center for chronic diarrhea, diurnal abdominal pain, and mild failure to thrive. His mother reported that symptoms were related to wheat ingestion and that resolved on a gluten-free diet; therefore, she was worried about Celiac Disease. However, blood tests did support neither celiac disease because of antitransglutaminase-IgA, anti-endomysium, and anti-gliadinIgA negativity nor wheat allergy for the absence of specific IgE for wheat or gluten. G was positive just to anti-gliadinIgG. We reassured the mother and concluded for a chronic unspecific diarrhea to be treated conservatively without elimination diets. On the follow-up visit, G was still complaining with same symptoms, and his growth was further slowing; we ,therefore, decided to repeat the blood tests (with similar results), to define the HLA status (DQ1/ 7), and to perform intestinal duodenal biopsies. These showed normal villous architecture and a modest increase of intraepithelial lymphocytes. Based on the clear association between clinical symptoms and wheat ingestion, the final diagnosis was ''non IgE-mediated adverse reaction to wheat,'' although G had no other clue to support this diagnosis such as personal or family history of atopy and/or eczema. G was started on a gluten-free diet with resolution of symptoms. This diagnosis was confirmed 6 months later with a double-blind placebo-controlled challenge that resulted in the onset of diarrhea and abdominal pain 30 h after wheat ingestion. This was happening in 2006 and 2 years later a ''new'' disease entity might have better explained the symptoms of this child: NCGS.
Keywords Non-celiac gluten sensitivity Á Abdominal pain Á Pediatric gastroenterology This entity had firstly been described more than 30 years ago in eight adult females suffering from abdominal pain and chronic diarrhea which had dramatic relief on a glutenfree diet (GFD) and return of symptoms after gluten challenge [3] . In the same years, Ellis and Linaker [4] described normal biopsies and normal lymphocyte counts existing in combination with rapid disappearance of symptoms when their patients withdrew gluten from the diet.
Recently, the gluten-free market increased worldwide, partially sustained by a percentage of general population who consider themselves suffering from ''problems caused by gluten ingestion'' and who undergo a GFD without having a proper diagnosis. Paradoxically in US population, more people are aware of NCGS than they are of CD [5] . Nowadays, marketers estimate that 15 to 25 % of North American consumers want gluten-free foods, although doctors estimate that just 1 % have CD [6] although recently published data would suggest this to be an overestimation [7] .
The first recent description of NCGS has been reported by Sapone et al. [8] , while the existence of this condition has been confirmed by Biesiekierski et al. [9 • ] in 2011, who demonstrated for the first time that individuals with a history of gluten sensitive symptoms did indeed respond to a double-blind gluten challenge. Since then, several reports from different groups have been published. A large Italian retrospective study on 920 adult patients with irritable bowel syndrome (IBS) demonstrated that 30 % were positive to a wheat double-blind placebo-controlled food challenge (DBPCFC) and therefore classified as NCGS (74 % suffering from multiple food sensitivities) [10 • ]. Finally, a recent study on patients with diarrhea predominant IBS suggested that gluten withdrawal improved stool frequency, while its administration negatively influenced intestinal permeability [11] .
So far, NCGS has been extensively described in adults, while little evidence is available in pediatric age; however, in children, NCGS might have been diagnosed as non-IgEmediated adverse reaction to wheat. Our group described for the first time NGCS in 15 children referred for a clear association between gluten consumption and symptoms supporting the existence of this condition across all ages with clinical, serological, genetic, and histological features partially similar to those reported in adults [12 •• ] .
Definition
Gluten sensitivity is a condition in which symptoms are triggered by gluten ingestion, and where both allergic and autoimmune mechanisms have been ruled out (diagnosis by exclusion criteria). Patients should have negative celiac serology, negative histology for classical celiac villous atrophy, and negative IgE based tests. In order to avoid confusion with CD, sometimes defined as gluten-sensitive enteropathy, ''non celiac gluten sensitivity'' appeared as an improved definition [1, 2 •• ]. As triggering cereal proteins could include fractions other than gluten, some authors argue in favor of ''non-celiac wheat sensitivity'' [13] , a terminology that would, however, conflict with the possibility that other gluten-containing cereals (rye, barley) may be offensive for the ''gluten sensitive'' patient, an unexplored area.
Epidemiology
The prevalence of NCGS is not yet established, although it is commonly thought to be at least as common as CD and likely much more prevalent in adults than in children. It is estimated that up to 6 % (347/5.896 patients seen at the Center for Celiac Research, University of Maryland) of the general population might be affected [1] .
Tanpowpong et al. [7] reported that 5 % of children without CD avoid gluten-containing food, and that this dietetic restriction in a different cohort is associated with improvement of non-specific behavioral and gastrointestinal complaints [14] . However, it is unclear how many children reporting gluten avoidance were indeed affected by NCGS, as the vast majority of the children were neither tested for CD nor underwent an intestinal biopsy.
A recent population-based survey in 7,762 unselected US persons (aged 6 years or older participating to the National Health and Nutrition Examination Survey) responding to an interviewer-administered questionnaires showed that 0.55 % were following a gluten-free diet, suggesting NCGS to be affecting at most 0.55 % of the general population. [15] .
Finally, Aziz et al. [16] on a population of 1,002 adults describe a self-reported prevalence for NCGS of 13 % (female 79 %) with 3.7 % consuming a gluten-free diet and 0.8 % known to have a doctor diagnosis of CD; individuals with NCGS had an increased prevalence of fulfilling the Rome III criteria for IBS, in comparison with those without NCGS.
Pathogenesis
The pathogenesis of this condition is still debated, although recent data suggest a major role for abnormalities in the [17] . Recently, Brotveit et al. [18] showed that NCGS patient had and increased density of intraepithelial CD3(?) T cells at baseline and a significant increase in interferon-c mRNA following gluten challenge suggesting that the adaptive immune system may play a role in NCGS.
Animal models of GS may help to explain the genesis of GI symptoms in the absence of intestinal damage. Gluten sensitization of DQ8 mice increases acetylcholine release by the myenteric plexus after in vitro nerve stimulation. The increased acetylcholine release is accompanied by hypercontractility and dysmotility, characterized by the increased incidence of retroperistalsis and altered gastric emptying [19] .
The real trigger of NCGS is still to be defined. Gluten cannot be considered the sole agent responsible for symptoms and other proteins, such as-amylase/trypsin inhibitor (ATI) or even yeast, may be involved; in addition, some of the carbohydrates escape small-bowel digestion and absorption, and may cause abdominal discomfort and diarrhea. Moreover, the trigger/s of mucosal events leading to NCGS may not be necessarily represented by the same array of gluten peptides responsible for the CD development. In NCGS patients, gliadin fractions do not provoke a clear picture of inflammation upon contact with the duodenal mucosa or with peripheral basophils [20] . In vitro studies suggest that wheat ATIs could play a major role as triggers of the innate immune response in GS [21] .
In 2013, Biesiekirski et al. [22] provided evidence that carbohydrates may be responsible for symptoms thought to be related to NCGS. They reported 37 patients with IBS/ self-reported NCGS who were assigned to a period of reduced low-fermentable, poorly absorbed, short-chain carbohydrates (fermentable oligo-, di-, and mono-saccharides and polyols = FODMAPs) diet, and then placed on either a gluten or whey proteins challenge. In all participants, gastrointestinal complaints consistently improved during reduced FODMAP intake but significantly worsened to a similar degree when their diets included gluten or whey proteins [22] . FODMAPS list includes fructans, galactans, fructose, and polyols that are contained in several foodstuffs, including wheat, vegetables, and milk derivatives. These results raise the possibility that the positive effect of the GFD in patients with IBS is an unspecific consequence of reducing FODMAPs intake, given that wheat is one of the possible sources of FODMAPs.
Clinical Picture and Diagnosis
So far, NCGS has been described only in adults, and no data are available for the pediatric population. We have recently described a series of 15 children (M: 10; median age: 10, 3 years, range 1, 6-15 years) diagnosed as having NCGS in tertiary referral centers for CD. All children were referred for a clear association of wheat ingestion and symptoms to confirm/exclude an adverse food reaction [12] . For comparison, 15 children with active CD diagnosed according to the European Society of Pediatric Gastroenterology, Hepatology, and Nutrition criteria [23] , and 15 control children enrolled from the children followed in our outpatient clinic for functional disorders [24] without CD and with no association between symptoms and any particular food were recruited.
After exclusion of CD and WA to confirm the diagnosis of NCGS, a ''single blind parent-aware'' gluten challenge was performed. Before the challenge, gluten had been withdrawn from the patient's diet for at least 8 weeks, and the challenge was performed in a hospital setting by administering gluten-containing food in increasing doses until a cumulative dose of at least 5 g was reached after 24 h. The children were asked to record all symptoms in a diary provided, and children with a 30 % increase in scores were considered to have a positive challenge.
In our series, the clinical presentation was characterized by typical gastrointestinal symptoms, such as abdominal pain and chronic diarrhea (Table 1) . In this respect, this condition is similar to CD or functional disorders and therefore not suggestive specifically of NCGS. Interestingly, as compared to adults, the extra-intestinal manifestations were less frequent, the most common extraintestinal symptom being tiredness; none complained of behavioral changes, ''foggy mind,'' eczema and/or rash, muscle cramps, leg numbness, and weight loss as reported in adults. Unlike adult patients, NCGS in children was more common in males.
As well as adults, children lack a biochemical/serological/genetic marker of this condition. Native AntiGliadin Antibody (AGA) IgG was the most frequently detected antibody, found in 66 % of children with NCGS although with titers significantly lower in children with GS compared with those with CD. HLA typing showed the presence of DQ2 in 7 of 15 of children with NCGS (46 %). No difference was found in the determination of nutritional, biochemical, and inflammatory markers between NCGS and controls. Similarly to adults [25] , the positivity of native AGA-IgG and the presence of DQ2 were more common (about half of the cases) in NCGS than control children (Table 2) . Of note, AGA IgG disappears in adult NCGS patients after six moths of GFD [26] , while we do not have data on our pediatric population.
Histologic analysis revealed a normal to mildly inflamed mucosa in children with NCGS: 82 % were classified as Marsh 0 and 18 % were classified as Marsh 1. Intraepithelial Lymphocytes (IEL) counts were significantly lower in the children with NCGS compared with those with CD. Villanacci et al. [27] observed in adults a peculiar distribution of IEL with two morphological aspects: (a) cluster of T lymphocytes in the superficial epithelium and (b) linear disposition of T lymphocytes in the deeper part of the mucosa above the muscularis mucosae.
As mentioned, the lack of serological or histological markers makes the diagnosis of NCGS a clinical-only one, based on the exclusion of CD and WA and on gluten challenge.
However, open-food challenges are obviously open to the possible confounding effect of placebo/nocebo caused by gluten exclusion/consumption: thus, DBPCFC gluten challenge should be considered the best option to confirm NCGS diagnosis. In spite of this, current guidelines accept an open-food challenge [28] .
As it is unknown, if NGCS is a permanent or transitory condition, periodical reassessments (e.g., every 6-12 months) are strongly recommended [2] .
Is it Really a New Entity?
As previously mentioned, NCGS was originally described in the 1980s [3] and many authors observed children and adult patients with chronic diarrhea, bloating, abdominal pain, nausea, headaches, with normal small intestinal biopsy specimens, and the absence of CD antibodies who responded dramatically to a GFD [29] .
In pediatrics, NCGS might have been diagnosed as a non-IgE-mediated adverse reaction to wheat. In fact, the possible overlapping between NCGS and delayed allergic reaction to wheat proteins is still an open question. NonIgE-mediated reactions tend to be delayed, with the onset of symptoms occurring from 1 h to several days after ingestion of food. A significant proportion of children with food allergy do not have circulating food proteinspecific IgE and show negative results to skin prick tests [30] . At present, there is no diagnostic test for non-IgEmediated adverse reactions to food. Atopy Patch Tests (APTs) are not standardized and are not recommended for routine use by current guidelines [31] ; they might nevertheless be of help in excluding food allergy-related gastrointestinal symptoms, particularly for wheat allergy [32, 33] .
Furthermore, previous studies on food allergy include cases with clinical characteristics resembling NCGS. In 2006, Venter et al. [34] established the prevalence of sensitization to food allergens using food challenges among all 6-year-old children living on the Isle of Wight. One of the children described by Venter presenting with diarrhea and abdominal pain showed negative skin prick tests and positive wheat food challenge [34] . In a Finnish study [35] published in 2010 on the prognosis of wheat hypersensitivity, the authors describe four children with gastrointestinal symptoms related to gluten and confirmed by an open wheat challenge who were diagnosed as allergic to wheat despite a negative SPT to gluten and gliadin [35] . Finally, in a retrospective study [36] on 437 children with food protein-induced gastrointestinal symptoms, 41.7 % were managed successfully with a multiple elimination diet including wheat. This study, however, in addition to children with non-IgE-mediated gastrointestinal food allergies, also included children with allergic enteropathy and enterocolitis [36] . In children, the differential diagnosis between NCGS and non-IgE-mediated adverse reactions to wheat resides mainly on clinical observations: although more studies are needed, some considerations argue in favor of NCGS as a distinct clinical entity even in children.
Age appears to be a main criterion. In fact, nearly all children with wheat hypersensitivity become tolerant by adolescence: wheat tolerance is acquired by 59, 69, 84, and 96 %, by age 4, 6, 10, and 16, respectively [35] . Thus, the older the child, the less the chances of a non-IgE-mediated adverse reactions to wheat. Children in our series were older than the typical wheat hypersensitive child (66 % older than 10 years).
Furthermore, a majority of wheat allergic children suffer from other allergic stigmata such as positive family history for atopy, atopic dermatitis, or other food allergies [37] . As a consequence, the absence of these other factors would support NCGS: in our study, none of the patients with NCGS had atopic dermatitis, personal or family history of atopy, or wheat-dependent exercise-induced anaphylaxis.
What Next?
Currently, NCGS is surrounded by skepticism and surely there is more popular talking rather than scientific data, if we compare the citations in a web browser as opposed to Pubmed [38] . However, it is indeed the limited scientific literature on the topic that generates all the doubts. In the era of evidence-based medicine, there is a strong need for validated biomarkers to support a diagnosis not based on clinical subjective criteria. In their absence, several problems need to be addressed, among them first and foremost what type of rigorous diagnostic double-blind placebocontrolled process must be followed, in the absence of a valid biomarker: the type of antigen used, the dose, and the time of its administration, the way symptoms are reported and scored.
High priorities in the research agenda of NCGS are
• Reach an unequivocal definition for this syndrome.
• Define if indeed is gluten (or gluten alone) the real trigger for NCGS.
• Characterize the role of FODMAP: sometimes or always responsible?
• Understand how rigorous the exclusion of gluten has to be for NCGS patients.
• Are all types of wheat involved in NCGS? And what about rye and barley?
• Should gluten-free diet be continued for life? • Should we include NCGS in the classification of adverse food reaction in pediatrics? [39] .
Conclusions
NCGS, mainly in pediatrics, is an entity awaiting validation, diagnostic, and clinical definition and possibly pathogenic mechanism clarification. There is a need of ''separating the wheat from the chaff'' [40] and this can be achieved only with proper scientific information, and prospective, multi-center studies addressing the many unsolved issues on NCGS.
Until a specific biomarker of this condition is available, NCGS should be suspected only in selected children after a proper exclusion of CD and WA. Unmotivated gluten-free diet could be dangerous not only because of its cost but also for the risk to classify incorrectly patients.
